Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deductibles and Coinsurance | 8 | 2023 | 316 | 1.090 |
Why?
|
Bipolar Disorder | 4 | 2022 | 5078 | 0.210 |
Why?
|
Insurance, Health | 5 | 2020 | 2501 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 4 | 2022 | 3164 | 0.180 |
Why?
|
Medicaid | 6 | 2015 | 2815 | 0.170 |
Why?
|
Diabetes Mellitus | 4 | 2021 | 5889 | 0.160 |
Why?
|
Medicare Part D | 2 | 2015 | 354 | 0.140 |
Why?
|
Influenza Vaccines | 1 | 2023 | 766 | 0.130 |
Why?
|
Cost of Illness | 2 | 2019 | 1940 | 0.130 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2019 | 457 | 0.130 |
Why?
|
Health Expenditures | 6 | 2022 | 2362 | 0.130 |
Why?
|
Gastric Bypass | 1 | 2024 | 829 | 0.120 |
Why?
|
Hepatitis B, Chronic | 1 | 2019 | 403 | 0.120 |
Why?
|
Reimbursement Mechanisms | 2 | 2011 | 664 | 0.120 |
Why?
|
Medically Uninsured | 1 | 2020 | 843 | 0.120 |
Why?
|
Postnatal Care | 1 | 2016 | 260 | 0.110 |
Why?
|
Financing, Personal | 1 | 2016 | 309 | 0.110 |
Why?
|
Asthma | 2 | 2023 | 6172 | 0.110 |
Why?
|
Insurance Claim Review | 5 | 2019 | 738 | 0.110 |
Why?
|
Blood Glucose | 2 | 2019 | 6381 | 0.110 |
Why?
|
Antipsychotic Agents | 2 | 2022 | 3061 | 0.110 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1287 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2019 | 1348 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1528 | 0.100 |
Why?
|
Glucose Intolerance | 1 | 2016 | 580 | 0.100 |
Why?
|
Prenatal Care | 1 | 2019 | 1129 | 0.100 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2020 | 1200 | 0.090 |
Why?
|
Antidepressive Agents | 2 | 2015 | 2890 | 0.090 |
Why?
|
Health Benefit Plans, Employee | 1 | 2013 | 333 | 0.090 |
Why?
|
Gastrointestinal Diseases | 2 | 2011 | 1190 | 0.080 |
Why?
|
Hepatitis C | 1 | 2019 | 1579 | 0.080 |
Why?
|
Postpartum Period | 1 | 2016 | 1167 | 0.080 |
Why?
|
Psychotropic Drugs | 1 | 2015 | 883 | 0.080 |
Why?
|
Medicare | 4 | 2015 | 6786 | 0.080 |
Why?
|
Organizational Policy | 1 | 2011 | 429 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3455 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 2125 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2024 | 7818 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3061 | 0.070 |
Why?
|
Dyspepsia | 2 | 2005 | 118 | 0.070 |
Why?
|
Family Characteristics | 1 | 2011 | 1001 | 0.070 |
Why?
|
Diabetes, Gestational | 1 | 2016 | 1242 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12293 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 626 | 0.070 |
Why?
|
Indiana | 3 | 2011 | 93 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 748 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1673 | 0.060 |
Why?
|
Michigan | 3 | 2011 | 342 | 0.060 |
Why?
|
Health Care Costs | 3 | 2024 | 3258 | 0.060 |
Why?
|
Antihypertensive Agents | 2 | 2013 | 2061 | 0.060 |
Why?
|
Histamine H2 Antagonists | 1 | 2005 | 167 | 0.060 |
Why?
|
Schizophrenia | 2 | 2015 | 6915 | 0.050 |
Why?
|
Middle Aged | 18 | 2024 | 220352 | 0.050 |
Why?
|
Albuterol | 1 | 2023 | 212 | 0.050 |
Why?
|
United States | 11 | 2024 | 72461 | 0.050 |
Why?
|
Medical Savings Accounts | 1 | 2022 | 34 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2010 | 1091 | 0.050 |
Why?
|
Humans | 29 | 2024 | 760621 | 0.050 |
Why?
|
Adult | 16 | 2024 | 219994 | 0.050 |
Why?
|
Helicobacter pylori | 1 | 2005 | 377 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 3018 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3202 | 0.050 |
Why?
|
Helicobacter Infections | 1 | 2005 | 386 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2013 | 1830 | 0.050 |
Why?
|
Health Surveys | 1 | 2010 | 4063 | 0.040 |
Why?
|
Female | 19 | 2024 | 391270 | 0.040 |
Why?
|
Proton Pump Inhibitors | 1 | 2005 | 551 | 0.040 |
Why?
|
Pandemics | 3 | 2024 | 8624 | 0.040 |
Why?
|
Disabled Persons | 1 | 2009 | 1223 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14495 | 0.040 |
Why?
|
Gastrectomy | 1 | 2024 | 679 | 0.040 |
Why?
|
Patient Compliance | 1 | 2009 | 2688 | 0.040 |
Why?
|
Insurance Carriers | 1 | 2020 | 156 | 0.040 |
Why?
|
Managed Care Programs | 1 | 2003 | 939 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15757 | 0.040 |
Why?
|
Drug Costs | 2 | 2019 | 1185 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2013 | 4360 | 0.040 |
Why?
|
Depression | 2 | 2015 | 8044 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2020 | 421 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2013 | 5397 | 0.030 |
Why?
|
Male | 15 | 2024 | 359744 | 0.030 |
Why?
|
Young Adult | 7 | 2022 | 58741 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6853 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1677 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2011 | 15840 | 0.030 |
Why?
|
Occult Blood | 1 | 2016 | 197 | 0.030 |
Why?
|
Adolescent | 8 | 2022 | 87810 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2024 | 80372 | 0.030 |
Why?
|
Health Services Misuse | 1 | 2016 | 245 | 0.030 |
Why?
|
Aged | 9 | 2021 | 169152 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1175 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7408 | 0.030 |
Why?
|
Drug Utilization | 2 | 2010 | 1195 | 0.030 |
Why?
|
Prevalence | 3 | 2019 | 15687 | 0.030 |
Why?
|
Weight Loss | 1 | 2024 | 2686 | 0.030 |
Why?
|
Child | 4 | 2023 | 79806 | 0.030 |
Why?
|
Vaccination | 1 | 2023 | 3361 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3520 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21025 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7806 | 0.020 |
Why?
|
Family | 1 | 2021 | 3189 | 0.020 |
Why?
|
Fees, Pharmaceutical | 1 | 2010 | 66 | 0.020 |
Why?
|
Public Sector | 1 | 2011 | 265 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8594 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1529 | 0.020 |
Why?
|
Fee-for-Service Plans | 1 | 2015 | 705 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3529 | 0.020 |
Why?
|
Africa | 1 | 2011 | 705 | 0.020 |
Why?
|
Gatekeeping | 1 | 2009 | 49 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2020 | 1939 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2013 | 496 | 0.020 |
Why?
|
New Hampshire | 1 | 2008 | 173 | 0.020 |
Why?
|
Maine | 1 | 2008 | 145 | 0.020 |
Why?
|
Colonoscopy | 1 | 2016 | 1387 | 0.020 |
Why?
|
Hospitalization | 2 | 2022 | 10790 | 0.020 |
Why?
|
Health Services | 1 | 2011 | 753 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2062 | 0.020 |
Why?
|
Pregnancy | 2 | 2019 | 29749 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2932 | 0.020 |
Why?
|
Cohort Studies | 4 | 2011 | 41335 | 0.020 |
Why?
|
World Health Organization | 1 | 2011 | 1312 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22053 | 0.020 |
Why?
|
Respiration | 1 | 2011 | 1654 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2011 | 2698 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2011 | 2435 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8035 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39261 | 0.010 |
Why?
|
Fever | 1 | 2011 | 1617 | 0.010 |
Why?
|
Gastric Acid | 1 | 2003 | 98 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8803 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11152 | 0.010 |
Why?
|
Anti-Ulcer Agents | 1 | 2003 | 113 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18416 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5877 | 0.010 |
Why?
|
Peptic Ulcer | 1 | 2003 | 219 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6360 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7269 | 0.010 |
Why?
|
New England | 1 | 2003 | 1050 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5423 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3150 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9716 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2295 | 0.010 |
Why?
|
Probability | 1 | 2003 | 2475 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12159 | 0.010 |
Why?
|
Hospitals | 1 | 2011 | 3928 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 2893 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2009 | 1925 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65017 | 0.010 |
Why?
|
Research Design | 1 | 2013 | 6180 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13314 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 816 | 0.010 |
Why?
|
Health Policy | 1 | 2008 | 2677 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58995 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12531 | 0.010 |
Why?
|
Population Surveillance | 1 | 2003 | 2608 | 0.010 |
Why?
|
Infant | 1 | 2011 | 36060 | 0.010 |
Why?
|
Child, Preschool | 1 | 2011 | 42063 | 0.000 |
Why?
|
Chronic Disease | 1 | 2003 | 9287 | 0.000 |
Why?
|
Incidence | 1 | 2003 | 21392 | 0.000 |
Why?
|
Prognosis | 1 | 2003 | 29658 | 0.000 |
Why?
|
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_